Chargement en cours...
PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target
Hypofibrinolysis is a key abnormality in diabetes and contributes to the adverse vascular outcome in this population. Plasminogen activator inhibitor (PAI)-1 is an important regulator of the fibrinolytic process and levels of this antifibrinolytic protein are elevated in diabetes and insulin resista...
Enregistré dans:
| Publié dans: | Int J Mol Sci |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8003717/ https://ncbi.nlm.nih.gov/pubmed/33804680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22063170 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|